fluorouracil has been researched along with pyrimidin-2-one beta-ribofuranoside in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Echigo, S; Nishimura, K; Rikiishi, H; Shinohara, F; Suzuki, M | 1 |
Echigo, S; Endo, M; Rikiishi, H; Shinohara, F; Sugazaki, M; Suzuki, M | 1 |
Flis, K; Flis, S; Gnyszka, A | 1 |
3 other study(ies) available for fluorouracil and pyrimidin-2-one beta-ribofuranoside
Article | Year |
---|---|
Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; Cytidine; DNA Methylation; Epigenesis, Genetic; Fluorouracil; Humans; Hydroxamic Acids; Mouth Neoplasms; Vorinostat | 2007 |
Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cytidine; DNA (Cytosine-5-)-Methyltransferases; Fluorouracil; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HSP90 Heat-Shock Proteins; Humans; In Situ Nick-End Labeling; Lactams, Macrocyclic; Lithium Chloride; Mouth Neoplasms; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2009 |
DNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in SW48 and HT-29 colorectal cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; DNA Damage; DNA-Cytosine Methylases; Enzyme Inhibitors; Fluorouracil; Humans; Membrane Potential, Mitochondrial; Organoplatinum Compounds; Oxaliplatin | 2014 |